Type, rather than number, of mental and physical comorbidities increases the severity of symptoms in patients with irritable bowel syndrome
Irritable bowel syndrome (IBS) has significant mental and physical comorbidities. However, little is known about the day-to-day burden these comorbidities place on quality of life (QOL), physical and mental function, distress, and symptoms of patients. We collected cross-sectional data from 175 pati...
Uložené v:
| Vydané v: | Clinical gastroenterology and hepatology Ročník 11; číslo 9; s. 1147 |
|---|---|
| Hlavní autori: | , , , , , , , , , , , , |
| Médium: | Journal Article |
| Jazyk: | English |
| Vydavateľské údaje: |
United States
01.09.2013
|
| Predmet: | |
| ISSN: | 1542-7714, 1542-7714 |
| On-line prístup: | Zistit podrobnosti o prístupe |
| Tagy: |
Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
|
| Abstract | Irritable bowel syndrome (IBS) has significant mental and physical comorbidities. However, little is known about the day-to-day burden these comorbidities place on quality of life (QOL), physical and mental function, distress, and symptoms of patients.
We collected cross-sectional data from 175 patients with IBS, which was diagnosed on the basis of Rome III criteria (median age, 41 years; 78% women), who were referred to 2 specialty care clinics. Patients completed psychiatric interviews, a physical comorbidity checklist, the IBS Symptom Severity Scale, the IBS-QOL instrument, the Brief Symptom Inventory, the abdominal pain intensity scale, and the Short Form-12 Health Survey.
Patients with IBS reported an average of 5 comorbidities (1 mental, 4 physical). Subjects with more comorbidities reported worse QOL after adjusting for confounding variables. Multiple linear regression analyses indicated that comorbidity type was more consistently and strongly associated with illness burden indicators than disease counts. Of 10,296 possible physical-mental comorbidity pairs, 6 of the 10 most frequent dyads involved specific conditions (generalized anxiety, depression, back pain, agoraphobia, tension headache, and insomnia). These combinations were consistently associated with greater illness and symptom burdens (QOL, mental and physical function, distress, more severe symptoms of IBS, and pain).
Comorbidities are common among patients with IBS. They are associated with distress and reduced QOL. Specific comorbidities are associated with more severe symptoms of IBS. |
|---|---|
| AbstractList | Irritable bowel syndrome (IBS) has significant mental and physical comorbidities. However, little is known about the day-to-day burden these comorbidities place on quality of life (QOL), physical and mental function, distress, and symptoms of patients.
We collected cross-sectional data from 175 patients with IBS, which was diagnosed on the basis of Rome III criteria (median age, 41 years; 78% women), who were referred to 2 specialty care clinics. Patients completed psychiatric interviews, a physical comorbidity checklist, the IBS Symptom Severity Scale, the IBS-QOL instrument, the Brief Symptom Inventory, the abdominal pain intensity scale, and the Short Form-12 Health Survey.
Patients with IBS reported an average of 5 comorbidities (1 mental, 4 physical). Subjects with more comorbidities reported worse QOL after adjusting for confounding variables. Multiple linear regression analyses indicated that comorbidity type was more consistently and strongly associated with illness burden indicators than disease counts. Of 10,296 possible physical-mental comorbidity pairs, 6 of the 10 most frequent dyads involved specific conditions (generalized anxiety, depression, back pain, agoraphobia, tension headache, and insomnia). These combinations were consistently associated with greater illness and symptom burdens (QOL, mental and physical function, distress, more severe symptoms of IBS, and pain).
Comorbidities are common among patients with IBS. They are associated with distress and reduced QOL. Specific comorbidities are associated with more severe symptoms of IBS. Irritable bowel syndrome (IBS) has significant mental and physical comorbidities. However, little is known about the day-to-day burden these comorbidities place on quality of life (QOL), physical and mental function, distress, and symptoms of patients.BACKGROUND & AIMSIrritable bowel syndrome (IBS) has significant mental and physical comorbidities. However, little is known about the day-to-day burden these comorbidities place on quality of life (QOL), physical and mental function, distress, and symptoms of patients.We collected cross-sectional data from 175 patients with IBS, which was diagnosed on the basis of Rome III criteria (median age, 41 years; 78% women), who were referred to 2 specialty care clinics. Patients completed psychiatric interviews, a physical comorbidity checklist, the IBS Symptom Severity Scale, the IBS-QOL instrument, the Brief Symptom Inventory, the abdominal pain intensity scale, and the Short Form-12 Health Survey.METHODSWe collected cross-sectional data from 175 patients with IBS, which was diagnosed on the basis of Rome III criteria (median age, 41 years; 78% women), who were referred to 2 specialty care clinics. Patients completed psychiatric interviews, a physical comorbidity checklist, the IBS Symptom Severity Scale, the IBS-QOL instrument, the Brief Symptom Inventory, the abdominal pain intensity scale, and the Short Form-12 Health Survey.Patients with IBS reported an average of 5 comorbidities (1 mental, 4 physical). Subjects with more comorbidities reported worse QOL after adjusting for confounding variables. Multiple linear regression analyses indicated that comorbidity type was more consistently and strongly associated with illness burden indicators than disease counts. Of 10,296 possible physical-mental comorbidity pairs, 6 of the 10 most frequent dyads involved specific conditions (generalized anxiety, depression, back pain, agoraphobia, tension headache, and insomnia). These combinations were consistently associated with greater illness and symptom burdens (QOL, mental and physical function, distress, more severe symptoms of IBS, and pain).RESULTSPatients with IBS reported an average of 5 comorbidities (1 mental, 4 physical). Subjects with more comorbidities reported worse QOL after adjusting for confounding variables. Multiple linear regression analyses indicated that comorbidity type was more consistently and strongly associated with illness burden indicators than disease counts. Of 10,296 possible physical-mental comorbidity pairs, 6 of the 10 most frequent dyads involved specific conditions (generalized anxiety, depression, back pain, agoraphobia, tension headache, and insomnia). These combinations were consistently associated with greater illness and symptom burdens (QOL, mental and physical function, distress, more severe symptoms of IBS, and pain).Comorbidities are common among patients with IBS. They are associated with distress and reduced QOL. Specific comorbidities are associated with more severe symptoms of IBS.CONCLUSIONSComorbidities are common among patients with IBS. They are associated with distress and reduced QOL. Specific comorbidities are associated with more severe symptoms of IBS. |
| Author | Sitrin, Michael D Satchidanand, Nikhil Lackner, Jeffrey M Keefer, Laurie Ballou, Sarah K Krasner, Susan S Ma, Chang-Xing Katz, Leonard Naliboff, Bruce D Brenner, Darren M Gudleski, Gregory D Firth, Rebecca Mayer, Emeran A |
| Author_xml | – sequence: 1 givenname: Jeffrey M surname: Lackner fullname: Lackner, Jeffrey M email: lackner@buffalo.edu organization: Department of Medicine, University at Buffalo School of Medicine, SUNY, Buffalo, New York 14215, USA. lackner@buffalo.edu – sequence: 2 givenname: Chang-Xing surname: Ma fullname: Ma, Chang-Xing – sequence: 3 givenname: Laurie surname: Keefer fullname: Keefer, Laurie – sequence: 4 givenname: Darren M surname: Brenner fullname: Brenner, Darren M – sequence: 5 givenname: Gregory D surname: Gudleski fullname: Gudleski, Gregory D – sequence: 6 givenname: Nikhil surname: Satchidanand fullname: Satchidanand, Nikhil – sequence: 7 givenname: Rebecca surname: Firth fullname: Firth, Rebecca – sequence: 8 givenname: Michael D surname: Sitrin fullname: Sitrin, Michael D – sequence: 9 givenname: Leonard surname: Katz fullname: Katz, Leonard – sequence: 10 givenname: Susan S surname: Krasner fullname: Krasner, Susan S – sequence: 11 givenname: Sarah K surname: Ballou fullname: Ballou, Sarah K – sequence: 12 givenname: Bruce D surname: Naliboff fullname: Naliboff, Bruce D – sequence: 13 givenname: Emeran A surname: Mayer fullname: Mayer, Emeran A |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/23524278$$D View this record in MEDLINE/PubMed |
| BookMark | eNpN0M1KAzEQB_AgFWurD-BFcvTQ1iSb_TpK8QsKXuq5ZLOzbsomWZOsZZ_BlzbFCsLAzMBv_oeZoYmxBhC6oWRFCc3u9yv50a4YocmKxKL0DF3SlLNlnlM--TdP0cz7PSGs5GV-gaYsSRlneXGJvrdjDwvsRGjB4dAKg82gK3ALbBuswQTRYWFq3LejVzIu0mrrKlWroMBjZaQD4eMUA7CHL3AqjMdbP-o-WH0kuBcRm-DxQYUWKxeNqDrAlT1AF6WpndVwhc4b0Xm4PvU5en963K5flpu359f1w2Yp0zQLS1lkNa-LmlZZKggRvAEGpJFAZcWagiZ5UxQsyZgoeVXTBKIhHEoBRDSQMTZHd7-5vbOfA_iw08pL6DphwA5-RzkrUlqSvIj09kSHSkO9653Swo27vweyH8XkeJ8 |
| CitedBy_id | crossref_primary_10_1016_j_beth_2023_01_004 crossref_primary_10_1097_PSY_0000000000000644 crossref_primary_10_3389_fnins_2024_1502752 crossref_primary_10_1007_s10620_015_3892_5 crossref_primary_10_1097_MOG_0000000000000686 crossref_primary_10_1177_1756283X16663396 crossref_primary_10_3390_pharmaceutics15051460 crossref_primary_10_1097_MCG_0000000000001343 crossref_primary_10_1146_annurev_med_042320_014032 crossref_primary_10_1111_nmo_12647 crossref_primary_10_1007_s10620_022_07500_0 crossref_primary_10_1016_j_jpsychores_2016_07_006 crossref_primary_10_1016_j_pnpbp_2023_110839 crossref_primary_10_1016_j_cgh_2017_02_032 crossref_primary_10_1097_PRA_0000000000000877 crossref_primary_10_31146_1682_8658_ecg_192_8_5_117 crossref_primary_10_1016_j_cgh_2018_10_033 crossref_primary_10_1097_MD_0000000000023059 crossref_primary_10_1016_j_jpsychores_2019_109821 crossref_primary_10_1186_s13063_022_06554_9 crossref_primary_10_14309_ajg_0000000000001052 crossref_primary_10_1002_ueg2_12397 crossref_primary_10_1016_j_brat_2022_104063 crossref_primary_10_1016_j_jpsychores_2019_01_015 crossref_primary_10_1007_s10620_021_06963_x crossref_primary_10_1186_s10194_025_02098_w crossref_primary_10_1371_journal_pone_0245323 crossref_primary_10_3390_brainsci14040393 crossref_primary_10_1080_03007995_2021_1888705 crossref_primary_10_1038_s41395_018_0396_x crossref_primary_10_1016_j_addbeh_2024_108187 crossref_primary_10_1097_MCG_0000000000001510 crossref_primary_10_1007_s43076_024_00389_w crossref_primary_10_1016_j_jpsychores_2020_110261 crossref_primary_10_1016_j_cgh_2018_02_043 crossref_primary_10_1038_nrurol_2016_95 crossref_primary_10_1177_2050640613518774 crossref_primary_10_1111_apt_16589 crossref_primary_10_1016_j_phymed_2021_153527 crossref_primary_10_3389_fpsyg_2022_1031923 crossref_primary_10_1039_D0FO03340E crossref_primary_10_1016_j_jpsychores_2019_109836 crossref_primary_10_1038_ajg_2016_255 crossref_primary_10_1038_nrurol_2016_227 crossref_primary_10_1016_j_cgh_2023_09_013 crossref_primary_10_1016_j_jpsychores_2016_12_007 crossref_primary_10_1097_MPG_0000000000001390 crossref_primary_10_1053_j_gastro_2016_02_017 crossref_primary_10_1016_j_jpsychores_2017_11_005 crossref_primary_10_1111_apt_15325 crossref_primary_10_52711_0974_360X_2024_00652 crossref_primary_10_1007_s40141_020_00267_3 crossref_primary_10_1039_D2FO03408E crossref_primary_10_1097_CIN_0000000000000747 crossref_primary_10_1016_j_bbi_2020_11_035 crossref_primary_10_1097_MCG_0000000000000906 crossref_primary_10_1007_s10865_025_00576_9 crossref_primary_10_7475_kjan_2018_30_3_235 crossref_primary_10_1038_s41575_022_00662_2 crossref_primary_10_1097_MEG_0000000000000848 crossref_primary_10_1155_2019_1759842 crossref_primary_10_1038_ajg_2013_410 crossref_primary_10_1016_j_gtc_2016_02_001 crossref_primary_10_1016_j_jand_2021_01_007 crossref_primary_10_3390_diagnostics14161750 crossref_primary_10_1016_j_phymed_2023_155163 crossref_primary_10_1016_j_jpsychores_2017_06_005 crossref_primary_10_1111_nmo_13531 crossref_primary_10_1053_j_gastro_2016_02_027 crossref_primary_10_1016_j_brat_2022_104033 crossref_primary_10_1111_cns_12490 crossref_primary_10_3928_02793695_20160803_01 crossref_primary_10_1186_s12955_015_0311_8 crossref_primary_10_3748_wjg_v20_i39_14105 crossref_primary_10_3892_ijmm_2016_2471 crossref_primary_10_5812_jamm_36624 crossref_primary_10_3389_fpsyt_2020_00436 crossref_primary_10_1016_j_brat_2016_07_006 crossref_primary_10_1016_S2468_1253_20_30363_0 crossref_primary_10_1097_j_pain_0000000000003186 crossref_primary_10_1038_ajg_2014_241 |
| ContentType | Journal Article |
| Copyright | Copyright © 2013 AGA Institute. Published by Elsevier Inc. All rights reserved. |
| Copyright_xml | – notice: Copyright © 2013 AGA Institute. Published by Elsevier Inc. All rights reserved. |
| DBID | CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1016/j.cgh.2013.03.011 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1542-7714 |
| ExternalDocumentID | 23524278 |
| Genre | Journal Article |
| GrantInformation_xml | – fundername: NIDDK NIH HHS grantid: U01 DK077738 |
| GroupedDBID | --- --K .1- .FO 0R~ 1B1 1CY 1P~ 29B 4.4 457 53G 5GY 5VS AAEDT AAEDW AALRI AAQFI AAQQT AAXUO ABJNI ABLJU ABMAC ACGFS ADBBV ADPAM AENEX AEVXI AFCTW AFJKZ AFRHN AFTJW AITUG AJUYK AKRWK ALMA_UNASSIGNED_HOLDINGS AMRAJ BELOY C45 C5W CGR CS3 CUY CVF DU5 EBS ECM EIF EJD F5P FDB FRP HZ~ IHE KOM M41 MO0 N9A NPM NQ- O9- OBH OC. ON0 OVD P2P RIG ROL RPZ SEL SES TEORI UV1 XH2 Z5R 7X8 AAFWJ EFJIC EFKBS |
| ID | FETCH-LOGICAL-c556t-c86d4d8d1b65a00a4fe2e0fce1cb2f8137f882362a94bd13e00a04e9ae0afe622 |
| IEDL.DBID | 7X8 |
| ISICitedReferencesCount | 94 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000323816100021&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1542-7714 |
| IngestDate | Sun Sep 28 09:14:33 EDT 2025 Thu Jan 02 22:11:49 EST 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 9 |
| Keywords | PCS Irritable Bowel Syndrome Outcome Study low back pain global severity index Irritable Bowel Syndrome Symptom Severity Scale National Institutes of Health MDD MINI International Neuropsychiatric Interview generalized anxiety disorder major depression disorder BSI Transdiagnostic Mental Functioning IBS LBP GSI IBSOS DSM Diagnostic and Statistical Manual of Mental Disorders GI Brief Symptom Inventory Comorbidity irritable bowel syndrome SF-12 12-item Short Form GAD NIH Health-Related Quality of Life IBS-SSS Stress QOL gastrointestinal GERD MINI HRQOL SF-12 Physical Component Score MCS quality of life Chronic Disease SF-12 Mental Component Score gastroesophageal reflux disease |
| Language | English |
| License | Copyright © 2013 AGA Institute. Published by Elsevier Inc. All rights reserved. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c556t-c86d4d8d1b65a00a4fe2e0fce1cb2f8137f882362a94bd13e00a04e9ae0afe622 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| OpenAccessLink | http://doi.org/10.1016/j.cgh.2013.03.011 |
| PMID | 23524278 |
| PQID | 1428519078 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_1428519078 pubmed_primary_23524278 |
| PublicationCentury | 2000 |
| PublicationDate | 2013-09-01 |
| PublicationDateYYYYMMDD | 2013-09-01 |
| PublicationDate_xml | – month: 09 year: 2013 text: 2013-09-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | Clinical gastroenterology and hepatology |
| PublicationTitleAlternate | Clin Gastroenterol Hepatol |
| PublicationYear | 2013 |
| References | 9881538 - J Clin Psychiatry. 1998;59 Suppl 20:22-33;quiz 34-57 8178794 - Am J Epidemiol. 1994 Apr 15;139(8):813-8 8756998 - Vital Health Stat 2. 1996 Aug;(122):1-46 15896288 - Behav Res Ther. 2005 Jul;43(7):943-57 15129893 - Qual Life Res. 2004 May;13(4):833-44 15421433 - Gastroenterology. 1950 May;15(1 1):95-103 9500148 - Neuroimmunomodulation. 1997 May-Jun;4(3):134-53 26309916 - J Chronic Dis. 1970 Dec;23(7):455-68 9616281 - Eur J Cancer. 1997 Dec;33(14):2352-8 20362977 - Behav Res Ther. 2010 Jun;48(6):540-6 18420501 - N Engl J Med. 2008 Apr 17;358(16):1692-9 14739194 - BMJ. 2004 Jan 24;328(7433):220-2 8970491 - J Clin Epidemiol. 1996 Dec;49(12):1407-17 9808350 - Pain. 1998 Sep;77(3):253-60 20233451 - BMC Gastroenterol. 2010;10:31 21699821 - Clin Gastroenterol Hepatol. 2011 Nov;9(11):957-964.e1 18524691 - Clin Gastroenterol Hepatol. 2008 Aug;6(8):899-906 10763950 - Am J Gastroenterol. 2000 Apr;95(4):999-1007 21090962 - Annu Rev Med. 2011;62:381-96 10373274 - Brain Behav Immun. 1999 Jun;13(2):80-92 18287824 - Clin J Pain. 2008 Mar-Apr;24(3):199-203 17991822 - Psychosom Med. 2007 Dec;69(9):901-9 16554399 - Psychosom Med. 2006 Mar-Apr;68(2):312-20 11910364 - Gastroenterology. 2002 Apr;122(4):1140-56 15297905 - Int J Methods Psychiatr Res. 2004;13(2):69-92 6735075 - Gastroenterology. 1984 Aug;87(2):314-8 23045168 - Arthritis Rheum. 2013 Feb;65(2):291-302 7076017 - Gut. 1982 May;23(5):404-9 16005156 - Psychoneuroendocrinology. 2005 Nov;30(10):1050-8 16137329 - Health Qual Life Outcomes. 2005;3:51 17292480 - J Affect Disord. 2007 Nov;103(1-3):113-20 17394728 - Br J Gen Pract. 2007 Apr;57(537):268-70 3558716 - J Chronic Dis. 1987;40(5):373-83 15569123 - Aliment Pharmacol Ther. 2004 Nov 15;20(10):1195-203 9300512 - Psychol Med. 1997 Sep;27(5):1065-77 19959329 - J Clin Epidemiol. 2010 May;63(5):558-65 15786609 - Vital Health Stat 10. 2003 Nov;(214):1-83 17683600 - Health Qual Life Outcomes. 2007;5:52 11801263 - J Psychosom Res. 2002 Jan;52(1):35-44 12763390 - J Behav Ther Exp Psychiatry. 2003 Mar;34(1):11-23 3949235 - Gut. 1986 Jan;27(1):37-40 12117046 - Respir Med. 2002 Jun;96(6):450-60 18637089 - Am J Gastroenterol. 2008 Oct;103(10):2536-43 7323234 - Psychol Med. 1981 Nov;11(4):783-92 16223651 - J Clin Epidemiol. 2005 Nov;58(11):1090-100 15789940 - Qual Life Res. 2005 Feb;14(1):45-55 12851867 - Gastroenterology. 2003 Jul;125(1):19-31 17069973 - Pain. 2006 Dec 5;125(3):208-15 23062808 - J Psychosom Res. 2012 Nov;73(5):351-5 15939546 - Psychoneuroendocrinology. 2005 Nov;30(10):1043-9 9428819 - N Engl J Med. 1998 Jan 15;338(3):171-9 18366819 - Psychol Med. 2009 Jan;39(1):33-43 12921009 - J Behav Med. 2003 Aug;26(4):361-72 23031401 - J Pain. 2012 Oct;13(10):1016-27 14665811 - J Occup Environ Med. 2003 Dec;45(12):1257-66 21833813 - Qual Life Res. 2012 Jun;21(5):829-36 8628042 - Med Care. 1996 Mar;34(3):220-33 15184708 - Psychosom Med. 2004 May-Jun;66(3):435-41 10737048 - Prog Brain Res. 2000;122:25-34 11016119 - J Abnorm Psychol. 2000 Aug;109(3):504-11 22863120 - Neurogastroenterol Motil. 2012 Oct;24(10):895-913 17900326 - Am J Gastroenterol. 2007 Dec;102(12):2767-76 15661446 - Pain. 2005 Feb;113(3):369-75 16777329 - Pain. 2006 Aug;123(3):226-30 21615355 - Acta Neurol Scand. 2012 Mar;125(3):180-6 22846389 - Contemp Clin Trials. 2012 Nov;33(6):1293-310 19597174 - Ann Fam Med. 2009 Jul-Aug;7(4):357-63 18501257 - J Psychosom Res. 2008 Jun;64(6):573-82 9619963 - J Clin Epidemiol. 1998 May;51(5):367-75 21835591 - J Clin Epidemiol. 2012 Jan;65(1):100-6 12090379 - J Consult Clin Psychol. 2002 Jun;70(3):725-38 17483191 - Gut. 2007 Sep;56(9):1202-9 16173905 - Ann Behav Med. 2005 Oct;30(2):91-103 11721759 - Am J Gastroenterol. 2001 Nov;96(11):3122-9 9146781 - Aliment Pharmacol Ther. 1997 Apr;11(2):395-402 |
| References_xml | – reference: 11016119 - J Abnorm Psychol. 2000 Aug;109(3):504-11 – reference: 12851867 - Gastroenterology. 2003 Jul;125(1):19-31 – reference: 7076017 - Gut. 1982 May;23(5):404-9 – reference: 17483191 - Gut. 2007 Sep;56(9):1202-9 – reference: 8756998 - Vital Health Stat 2. 1996 Aug;(122):1-46 – reference: 12921009 - J Behav Med. 2003 Aug;26(4):361-72 – reference: 19597174 - Ann Fam Med. 2009 Jul-Aug;7(4):357-63 – reference: 18287824 - Clin J Pain. 2008 Mar-Apr;24(3):199-203 – reference: 10373274 - Brain Behav Immun. 1999 Jun;13(2):80-92 – reference: 8178794 - Am J Epidemiol. 1994 Apr 15;139(8):813-8 – reference: 18420501 - N Engl J Med. 2008 Apr 17;358(16):1692-9 – reference: 15786609 - Vital Health Stat 10. 2003 Nov;(214):1-83 – reference: 20362977 - Behav Res Ther. 2010 Jun;48(6):540-6 – reference: 18366819 - Psychol Med. 2009 Jan;39(1):33-43 – reference: 26309916 - J Chronic Dis. 1970 Dec;23(7):455-68 – reference: 17900326 - Am J Gastroenterol. 2007 Dec;102(12):2767-76 – reference: 19959329 - J Clin Epidemiol. 2010 May;63(5):558-65 – reference: 15939546 - Psychoneuroendocrinology. 2005 Nov;30(10):1043-9 – reference: 10737048 - Prog Brain Res. 2000;122:25-34 – reference: 12763390 - J Behav Ther Exp Psychiatry. 2003 Mar;34(1):11-23 – reference: 23045168 - Arthritis Rheum. 2013 Feb;65(2):291-302 – reference: 16173905 - Ann Behav Med. 2005 Oct;30(2):91-103 – reference: 11721759 - Am J Gastroenterol. 2001 Nov;96(11):3122-9 – reference: 15789940 - Qual Life Res. 2005 Feb;14(1):45-55 – reference: 23062808 - J Psychosom Res. 2012 Nov;73(5):351-5 – reference: 21835591 - J Clin Epidemiol. 2012 Jan;65(1):100-6 – reference: 17394728 - Br J Gen Pract. 2007 Apr;57(537):268-70 – reference: 14665811 - J Occup Environ Med. 2003 Dec;45(12):1257-66 – reference: 9808350 - Pain. 1998 Sep;77(3):253-60 – reference: 17292480 - J Affect Disord. 2007 Nov;103(1-3):113-20 – reference: 8628042 - Med Care. 1996 Mar;34(3):220-33 – reference: 12117046 - Respir Med. 2002 Jun;96(6):450-60 – reference: 9616281 - Eur J Cancer. 1997 Dec;33(14):2352-8 – reference: 22863120 - Neurogastroenterol Motil. 2012 Oct;24(10):895-913 – reference: 9500148 - Neuroimmunomodulation. 1997 May-Jun;4(3):134-53 – reference: 15661446 - Pain. 2005 Feb;113(3):369-75 – reference: 17069973 - Pain. 2006 Dec 5;125(3):208-15 – reference: 15129893 - Qual Life Res. 2004 May;13(4):833-44 – reference: 6735075 - Gastroenterology. 1984 Aug;87(2):314-8 – reference: 11910364 - Gastroenterology. 2002 Apr;122(4):1140-56 – reference: 14739194 - BMJ. 2004 Jan 24;328(7433):220-2 – reference: 11801263 - J Psychosom Res. 2002 Jan;52(1):35-44 – reference: 9300512 - Psychol Med. 1997 Sep;27(5):1065-77 – reference: 20233451 - BMC Gastroenterol. 2010;10:31 – reference: 16137329 - Health Qual Life Outcomes. 2005;3:51 – reference: 21090962 - Annu Rev Med. 2011;62:381-96 – reference: 9428819 - N Engl J Med. 1998 Jan 15;338(3):171-9 – reference: 7323234 - Psychol Med. 1981 Nov;11(4):783-92 – reference: 3558716 - J Chronic Dis. 1987;40(5):373-83 – reference: 10763950 - Am J Gastroenterol. 2000 Apr;95(4):999-1007 – reference: 23031401 - J Pain. 2012 Oct;13(10):1016-27 – reference: 22846389 - Contemp Clin Trials. 2012 Nov;33(6):1293-310 – reference: 9146781 - Aliment Pharmacol Ther. 1997 Apr;11(2):395-402 – reference: 18501257 - J Psychosom Res. 2008 Jun;64(6):573-82 – reference: 3949235 - Gut. 1986 Jan;27(1):37-40 – reference: 12090379 - J Consult Clin Psychol. 2002 Jun;70(3):725-38 – reference: 15421433 - Gastroenterology. 1950 May;15(1 1):95-103 – reference: 17683600 - Health Qual Life Outcomes. 2007;5:52 – reference: 8970491 - J Clin Epidemiol. 1996 Dec;49(12):1407-17 – reference: 21615355 - Acta Neurol Scand. 2012 Mar;125(3):180-6 – reference: 9881538 - J Clin Psychiatry. 1998;59 Suppl 20:22-33;quiz 34-57 – reference: 16005156 - Psychoneuroendocrinology. 2005 Nov;30(10):1050-8 – reference: 15297905 - Int J Methods Psychiatr Res. 2004;13(2):69-92 – reference: 16777329 - Pain. 2006 Aug;123(3):226-30 – reference: 16554399 - Psychosom Med. 2006 Mar-Apr;68(2):312-20 – reference: 15896288 - Behav Res Ther. 2005 Jul;43(7):943-57 – reference: 18524691 - Clin Gastroenterol Hepatol. 2008 Aug;6(8):899-906 – reference: 15184708 - Psychosom Med. 2004 May-Jun;66(3):435-41 – reference: 21833813 - Qual Life Res. 2012 Jun;21(5):829-36 – reference: 16223651 - J Clin Epidemiol. 2005 Nov;58(11):1090-100 – reference: 17991822 - Psychosom Med. 2007 Dec;69(9):901-9 – reference: 18637089 - Am J Gastroenterol. 2008 Oct;103(10):2536-43 – reference: 21699821 - Clin Gastroenterol Hepatol. 2011 Nov;9(11):957-964.e1 – reference: 15569123 - Aliment Pharmacol Ther. 2004 Nov 15;20(10):1195-203 – reference: 9619963 - J Clin Epidemiol. 1998 May;51(5):367-75 |
| SSID | ssj0029497 |
| Score | 2.4389608 |
| Snippet | Irritable bowel syndrome (IBS) has significant mental and physical comorbidities. However, little is known about the day-to-day burden these comorbidities... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | 1147 |
| SubjectTerms | Abdominal Pain - complications Adolescent Adult Aged Comorbidity Cross-Sectional Studies Female Humans Irritable Bowel Syndrome - pathology Irritable Bowel Syndrome - psychology Male Mental Disorders - complications Middle Aged Quality of Life Severity of Illness Index Young Adult |
| Title | Type, rather than number, of mental and physical comorbidities increases the severity of symptoms in patients with irritable bowel syndrome |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/23524278 https://www.proquest.com/docview/1428519078 |
| Volume | 11 |
| WOSCitedRecordID | wos000323816100021&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LS8QwEA6-EC--3w9G8GixSdvd5CQiihcXDwp7W_KYyIK263ZV_A3-aTNpV0-C4KWkkLQlmWa-zAzfx9hJ2BdzgxkmMsM0CXdFonVBrUJZL73RwkSxiW6vJ_t9ddcG3Oq2rHK6J8aN2lWWYuRnxAwW0EbwaOejl4RUoyi72kpozLL5LEAZKunq9r-zCELljbhKkROK5Pk0qxnru-wj5SJ4FjlOOf8dYUZPc73y329cZcstxoSLxijW2AyW62zxts2ib7BPOnyewjiCP6DYOTTCIKdQeWjY_kGXDkbtIkJ4fTU2QxfpV2FYEtSsQys8AIJrRVLAo7H1x_NoUj1TF2gZW2ugUC8MxxSFME8IpnrHJ5gyJWyyh-ur-8ubpBVlSGxRdCaJlR2XO-m46RQ6TXXuUWDqLXJrhJc863pJIupCq9w4Hiwg1WmOSmOqPXaE2GJzZVXiDgPDpQ7u0BvruqGvVVIqpzJUKRZaCNxlx9NpHgSjp0yGLrF6rQc_E73Ltpu1Gowado6BCJCS9EP2_jB6ny2JKG9BNWMHbN6HXx4P2YJ9mwzr8VG0pnDt3d1-AVG_2CQ |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Type%2C+rather+than+number%2C+of+mental+and+physical+comorbidities+increases+the+severity+of+symptoms+in+patients+with+irritable+bowel+syndrome&rft.jtitle=Clinical+gastroenterology+and+hepatology&rft.au=Lackner%2C+Jeffrey+M&rft.au=Ma%2C+Chang-Xing&rft.au=Keefer%2C+Laurie&rft.au=Brenner%2C+Darren+M&rft.date=2013-09-01&rft.eissn=1542-7714&rft.volume=11&rft.issue=9&rft.spage=1147&rft_id=info:doi/10.1016%2Fj.cgh.2013.03.011&rft_id=info%3Apmid%2F23524278&rft_id=info%3Apmid%2F23524278&rft.externalDocID=23524278 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1542-7714&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1542-7714&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1542-7714&client=summon |